bpc-157 human clinical evidence randomized trial BPC-157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven BPC-157 as an Investigational Peptide
Description
A meta-analysis of four observational studies, following a total of 7,475 older individuals for 3 to 16 years, found a weak association between an elevation in vitamin B 12 of 50 pmol/L in blood and a reduction in fracture risk (114)
12 For intranasal formulations, a PDI less than 0.3 is typically recommended, although this can vary depending on the type of lipid-based nanoparticle used
Persistently high homocysteine can also risk problems with the cardiovascular system and blood cell formation
Source only from suppliers with third-party certificates of analysis
